| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/28/2001 | WO2001046700A2 Sodium channels as targets for amyloid beta |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046455A2 Survivin promotion of angiogenesis |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046405A2 Modulation of pax-2 for controlled apoptosis or survival of cells |
| 06/28/2001 | WO2001046397A2 Human kinases |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046261A1 Method for treating inflammation |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046231A2 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | WO2001046223A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | WO2001046206A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046205A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046204A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | WO2001046203A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046199A1 Methods and compounds for inhibiting mrp1 |
| 06/28/2001 | WO2001046198A2 Nonpeptide kappa opioid receptor antagonists |
| 06/28/2001 | WO2001046196A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | WO2001046195A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 06/28/2001 | WO2001046192A1 SPIRO COMPOUNDS USEFUL AS OPIOID δ RECEPTOR AGONIST |
| 06/28/2001 | WO2001046191A1 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 06/28/2001 | WO2001046189A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 06/28/2001 | WO2001046184A1 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046183A1 SUBSTITUTED 1,3,4-OXADIAZOLES AND A METHOD OF REDUCING TNF-α LEVELS |
| 06/28/2001 | WO2001046178A2 Substituierte bisindolymaleimide |
| 06/28/2001 | WO2001046176A2 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001046174A1 Novel compounds |
| 06/28/2001 | WO2001046168A1 Tryptase inhibitors |
| 06/28/2001 | WO2001046167A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 06/28/2001 | WO2001046157A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | WO2001046155A1 Potassium channel inhibitors |
| 06/28/2001 | WO2001046146A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046145A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046144A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046140A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 06/28/2001 | WO2001046138A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | WO2001046137A1 Farnesyl transferase inhibitors |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046131A1 Method for making 24(s)-hydroxyvitamin d¿2? |
| 06/28/2001 | WO2001046128A2 Tryptase inhibitors |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001045836A2 Molecules derived from mechanism based drug design |
| 06/28/2001 | WO2001045765A1 Tissue regenerative composition |
| 06/28/2001 | WO2001045751A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | WO2001045746A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | WO2001045739A1 Remedies and/or preventives for nervous system disorders |
| 06/28/2001 | WO2001045733A1 Carbonyl stress-ameliorating agents |
| 06/28/2001 | WO2001045732A2 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/28/2001 | WO2001045715A2 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain |
| 06/28/2001 | WO2001045711A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045709A1 Substituted piperazine and piperidine calcium channel blockers |
| 06/28/2001 | WO2001045706A1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045702A1 SUBSTITUTED ACYLHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 06/28/2001 | WO2001045700A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045697A1 Skin external agents and drugs |
| 06/28/2001 | WO2001045691A2 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 06/28/2001 | WO2001045689A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2001 | WO2001045686A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045685A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045684A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045682A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045681A2 Naphthoquinone derivatives as cd45 inhibitors |
| 06/28/2001 | WO2001045664A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 06/28/2001 | WO2001045663A2 USE OF AROMATIC POLYCYCLIC COMPOUNDS AS ACTIVATORS OF PPARs-TYPE RECEPTORS IN A COSMETIC OR PHARMACEUTICAL COMPOSITION |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045650A2 Cosmetic use of the residues from wine production |
| 06/28/2001 | WO2001045641A2 Inhibitors of thrombin induced platelet aggregation |
| 06/28/2001 | WO2001045637A2 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides |
| 06/28/2001 | WO2001045548A2 Surgical needle with weeping tip and method of use |
| 06/28/2001 | WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | WO2001045484A2 An improved process for preparing simvastatin |
| 06/28/2001 | WO2001037667A8 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control |
| 06/28/2001 | WO2001014402A8 Antisense modulation of focal adhesion kinase expression |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO2001009122A3 Serotonergic benzofurans |
| 06/28/2001 | WO2001005414A8 Algae protein polysaccharide extraction and use thereof |
| 06/28/2001 | WO2001002561A3 Mammalian calcium channels and related probes, cell lines and methods |
| 06/28/2001 | WO2001002380A8 Antipsychotic cyclic n-aralkyl amines |
| 06/28/2001 | WO2000078776A3 Thiophene a2a receptor agonists |
| 06/28/2001 | WO2000077186A3 Bacterial protection against stress |
| 06/28/2001 | WO2000077010A3 Substituted heterocycle fused gamma-carbolines |
| 06/28/2001 | WO2000076527A3 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy |
| 06/28/2001 | WO2000075144A3 Peroxynitrite decomposition catalysts and methods of use thereof |
| 06/28/2001 | WO2000075142A3 Dna methyltransferase inhibitors |
| 06/28/2001 | WO2000071741A3 Dna encoding a human subunit of the 5-ht3 serotonin receptor |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO2000057865A3 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO2000040569A8 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 06/28/2001 | WO2000003981A8 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |